E

EOLO PHARMA

5 employees

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
small molecules and platform
Health Care
Pharmaceutical
Biopharma

Date founded

2017

Funding rounds raised

Total raised

$2.7M

from 2 investors over 2 rounds

E

EOLO PHARMA raised $2.7M on January 7, 2020

Investors: Ficus Group Capital and CITES - Centro de Innovación Tecnológica Empresarial y Social

FAQ